"We received 45,000 doses yesterday, the first 45,000 doses from AstraZeneca, and we expect more in the coming days," Themistokleous said
South Africa looks to J&J vaccine
Home-grown firms get new orders: 10 million for SII, 4.5 million for Bharat Bio
Drug firmAstraZeneca Pharma India on Monday reported a 21 per cent decline in net profit at Rs 21.05 crore for the quarter ended in December
Business Standard brings you top news of the evening
Prior to widespread circulation of the more contagious variant, the vaccine was showing efficacy of around 75%
The firm said it has received marketing authorisation to use its anti-diabetic drug dapagliflozin for the treatment of patients with chronic kidney disease
Company has started adapting vaccine against variant, shot may be ready by autumn this year
The WHO's initiative to provide equitable access to vaccines - COVAX - is devoid of the funds needed to procure and supply the shots to poorer countries.
AstraZeneca Pharma India on Saturday said it has received approval from the Drugs Controller General of India (DCGI) for Dapagliflozin
The variant, first identified in Kent, southern England, is more easily transmissible, prompting many countries to restrict travel to Britain
Britain has been rolling out the shot among all age groups after the Medicines and Healthcare products Regulatory Agency (MHRA) was the first regulator to approve it in December
The Astra and Pfizer vaccines will be given in different orders and with two dosing intervals, four and 12 weeks apart.
AstraZeneca said in December it would start clinical trials to test combining the two vaccines to see if this could boost the efficacy of the British shot.
Namaki also said that Iran's Razi Vaccine and Serum Research Institute has been authorized to start clinical trials of its vaccine candidate, and they will hopefully start the trials next week
As of now, Covax has not allotted the Pfizer-BioNTech vaccine for India.
As of now, Covax has not disclosed the India distribution plan for the Pfizer-BioNTech vaccine
Researchers measured the impact on transmission by swabbing participants every week seeking to detect signs of the virus
The decision could shake up the French vaccination strategy, because the country has prioritized nursing home residents and people over 75
Pfizer is commanding a higher price for its vaccine than some rivals